China's CARsgen Therapeutics plunges in Hong Kong debut

CARsgen Therapeutics Holdings

18/06/2021 03:00

** Shares of CARsgen Therapeutics Holdings Ltd  2171.HK 
trade as low as HK$26.60 in their Hong Kong debut, down 18.9%
from the IPO price of HK$32.80 apiece
    ** Stock is the second most actively traded shares by
turnover in early trade 
    ** The Shanghai-based chimeric antigen receptor-T cell
therapy developer offered 94.75 mln shares in Hong Kong IPO,
raising HK$3.11 bln ($400.6 mln) for development of core
products, R&D, and for developing manufacturing and
commercialization capabilities  urn:newsml:reuters.com:*:nFWN2NN0BE
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
rises 1.7%
    ** The Hang Seng China enterprises index  .HSCE  climbs
0.7%, and the benchmark index  .HSI  gains 0.8%

   ($1 = 7.7637 Hong Kong dollars)

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)